The FDA’s Office of Pharmaceutical Quality finally has a debut date. Regulatory Focus reports that the long-anticipated division will open January 1.

RF notes that the Center for Drug Evaluation and Research’s director Janet Woodcock proposed the new unit two years ago as part of a plan to help the regulator improve drug quality, but several resignations sidelined the project in 2013.